Revisión sistemática sobre factores de riesgo asociados a artralgia persistente en el paciente con fiebre del chikunguña
Publicado
abr 12, 2018
Almetrics
Dimensions
Google Scholar
##plugins.themes.bootstrap3.article.details##
Resumen
Antecedente: La fiebre del chikunguña es una enfermedad tropical infecciosa, caracterizada por la aparición de fiebre, erupción cutánea y artralgias, cuya incidencia ha aumentado en los últimos años, en Asia y Latinoamérica. Aunque es una enfermedad con baja mortalidad, se ha relacionado con limitación funcional a largo plazo, por su compromiso articular. Objetivo: Llevar a cabo una revisión sistemática de la literatura sobre los factores de riesgo asociados a artralgia persistente en el paciente con fiebre de chikunguña. Metodología: Se buscó información en bases de datos como PubMed, Embase, ScienceDirect, Scopus y Google Académico, con el descriptor de búsqueda (chikungunya fever OR chikungunya) AND (arthralgia). Resultados: Se obtuvieron 4281 estudios de los cuales al final se seleccionaron seis estudios de cohorte por su similitud metodológica en la evaluación de factores asociados y de los que se obtuvieron diferentes resultados en el análisis de datos.
Keywords
chikungunya fever, arthralgia, chikungunya virus, risk factors.fiebre chikunguña, artralgia, factores de riesgo
References
1. Couderc T, Lecuit M. Chikungunya virus pathogenesis: From bedside to bench. Antiviral Res. 2015 Sep;121:120-31.
2. Powers AM, Brault AC, Shirako Y, Strauss EG, Kang W, Strauss JH, et al. Evolutionary relationships and systematics of the alphaviruses. J Virol. 2001 Nov;75(21):10118-31.
3. Robinson MC. An epidemic of virus disease in Southern Province, Tanganyika territory, in 1952-1953. Trans R Soc Trop Med Hyg. 1955 Jan 1;49(1):28-32.
4. Strauss JH, Strauss EG. The alphaviruses: gene expression, replication, and evolution. Microbiol Rev. 1994 Sep;58(3):491-562.
5. Jose J, Snyder JE, Kuhn RJ. A structural and functional perspective of alphavirus replication and assembly. Future Microbiol. 2009 Sep;4:837-56.
6. Thiberville S-D, Moyen N, Dupuis-Maguiraga L, Nougairede A, Gould
EA, Roques P, et al. Chikungunya fever: Epidemiology, clinical syndrome,
pathogenesis and therapy. Antiviral Res. 2013 Sep;99(3):345-70.
7. Suhrbier A, Jaffar-Bandjee M-C, Gasque P. Arthritogenic alphaviruses
—an overview. Nat Rev Rheumatol. 2012 Jul;8(7):420-9.
8. Halstead SB. Reappearance of Chikungunya, Formerly Called Dengue,
in the Americas. Emerg Infect Dis [Internet]. 2015 Apr [citado 2016 oct
25];21(4). Disponible en: http://wwwnc.cdc.gov/eid/article/21/4/14-
1723_article.htm.
9. Gérardin P, Guernier V, Perrau J, Fianu A, Le Roux K, Grivard P, et al.
Estimating Chikungunya prevalence in La Réunion Island outbreak by
serosurveys: Two methods for two critical times of the epidemic. BMC
Infect Dis. 2008 Jul 28;8:99.
10. Weaver SC, Lecuit M. Chikungunya virus and the global spread of a
mosquito-borne disease. N Engl J Med. 2015 Mar 26;372(13):1231-9.
11. Pialoux G, Gaüzère B-A, Jauréguiberry S, Strobel M. Chikungunya, an
epidemic arbovirosis. Lancet Infect Dis. 2007 May;7(5):319-27.
12. Mohan A, Kiran DHN, Manohar IC, Kumar DP. Epidemiology, clinical
manifestations, and diagnosis of Chikungunya fever: lessons learned from
the re-emerging epidemic. Indian J Dermatol. 2010 Jan;55(1):54-63.
13. Mavalankar D, Shastri P, Raman P. Chikungunya epidemic in India: A
major public-health disaster. Lancet Infect Dis. 2007 May;7(5):306-7.
14. Bhatia R, Narain JP. Re-emerging chikungunya fever: some lessons
from Asia. Trop Med Int Health. 2009 Aug 1;14(8):940-6.
15. Team EC for DP and C(ECDC)-HCU-E editorial. An outbreak of
chikungunya fever in the province of Ravenna, Italy. European Centre for
Disease Prevention and Control(ECDC) - Health Comunication Unit; 2007.
16. Van Bortel W, Dorleans F, Rosine J, Blateau A, Rousset D, Matheus S,
et al. Chikungunya outbreak in the Caribbean region, December 2013 to
March 2014, and the significance for Europe. Euro Surveill [Internet].
2014;19(13). Disponible en:
http://www.eurosurveillance.org/content/10.2807/1560-
7917.ES2014.19.13.20759#html_fulltext
17. Organización Panamericana de la Salud, Organización Mundial de la
Salud. Chikunguña: datos, mapas y estadísticas. Semana
epidemiológica/SE 42. 21 de octubre de 2016. 2016 [citado 2016 oct 25].
Disponible en: http://www.paho.org/hq/index.php?
option=com_topics&view=readall&cid=5932&Itemid=40931&lang=es.
18. Durán M, Gómez S. Chikunguña en Colombia, el inicio de la
transmisión autóctona, 2014. Inf Quinc Epidemiológico Nac [Internet].
2014;19(18). Disponible en: http://www.ins.gov.co/iqen/IQUEN/IQEN
%20vol %2019 %202014 %20num %2018.pdf.
19. Instituto Nacional de Salud. Boletín Epidemiológico Semanal
[Internet]. 2016 [citado 2016 oct 25];(41). Disponible en:
http://www.ins.gov.co/boletin-epidemiologico/Boletn
%20Epidemiolgico/2015 %20Boletin %20epidemiologico %20semana %2041.pdf.
20. Burt FJ, Rolph MS, Rulli NE, Mahalingam S, Heise MT. Chikungunya: a
re-emerging virus. The Lancet. 2012 Feb;379(9816):662-71.
21. Borgherini G, Poubeau P, Staikowsky F, Lory M, Moullec NL, Becquart
JP, et al. Outbreak of Chikungunya on Reunion Island: Early clinical and
laboratory features in 157 adult patients. Clin Infect Dis. 2007 Jun
1;44(11):1401-7.
22. Lo Presti A, Lai A, Cella E, Zehender G, Ciccozzi M. Chikungunya
virus, epidemiology, clinics and phylogenesis: A review. Asian Pac J Trop
Med. 2014 Dec 1;7(12):925-32.
23. Rezza G, Nicoletti L, Angelini R, Romi R, Finarelli A, Panning M, et al.
Infection with chikungunya virus in Italy: an outbreak in a temperate
region. The Lancet. 2007 Dec 7;370(9602):1840-6.
24. Paul BJ, Pannarkady G, Moni SP, Thachil EJ. Clinical profile and long-
term sequelae of Chikungunya fever. Indian J Rheumatol. 2011 Mar
1;6(1):12-9.
25. Daginawala H, Chandak N, Kashyap R, Kabra D, Karandikar P, Saha S,
et al. Neurological complications of Chikungunya virus infection. Neurol
India. 2009;57(2):177.
26. Moro ML, Grilli E, Corvetta A, Silvi G, Angelini R, Mascella F, et al.
Long-term chikungunya infection clinical manifestations after an outbreak
in Italy: A prognostic cohort study. J Infect. 2012 Aug 1;65(2):165-72.
27. World Health Organisation. Guidelines on clinical management of
chikunguña fever [Internet]. 2008 [citado 2016 oct 25]. Disponible en: http://www.wpro.who.int/mvp/topics/ntd/Clinical_Mgnt_Chikungunya_WH
O_SEARO.pdf.
28. de Andrade DC, Jean S, Clavelou P, Dallel R, Bouhassira D. Chronic
pain associated with the Chikungunya Fever: long lasting burden of an
acute illness. BMC Infect Dis. 2010;10:31.
29. Manimunda SP, Vijayachari P, Uppoor R, Sugunan AP, Singh SS, Rai
SK, et al. Clinical progression of chikungunya fever during acute and
chronic arthritic stages and the changes in joint morphology as revealed by
imaging. Trans R Soc Trop Med Hyg. 2010 Jun;104(6):392-9.
30. Larrieu S, Pouderoux N, Pistone T, Filleul L, Receveur M-C, Sissoko D,
et al. Factors associated with persistence of arthralgia among chikungunya
virus-infected travellers: Report of 42 French cases. J Clin Virol. 2010 Jan
1;47(1):85-8.
31. Borgherini G, Poubeau P, Jossaume A, Gouix A, Cotte L, Michault A, et
al. Persistent arthralgia associated with chikungunya virus: a study of 88
adult patients on reunion island. Clin Infect Dis Off Publ Infect Dis Soc Am.
2008;47(4):469-75.
32. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis
JPA, et al. The PRISMA statement for reporting systematic reviews and
meta-analyses of studies that evaluate healthcare interventions:
explanation and elaboration. BMJ. 2009 Dec 4;339(jul21 1):b2700-b2700.
33. Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The
Newcastle-Ottawa Scale(NOS) for assessing the quality of nonrandomised
studies in meta-analyses [Internet]. [Citado 2016 oct 25]. Disponible en:
http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
34. Schilte C, Staikovsky F, Couderc T, Madec Y, Carpentier F, Kassab S,
et al. Chikungunya virus-associated long-term arthralgia: a 36-month
prospective longitudinal study. PLOS Negl Trop Dis. 2013 Mar
21;7(3):e2137.
35. Ramachandran V, Kaur P, Kanagasabai K, Vadivoo S, Murhekar M.
Persistent arthralgia among Chikungunya patients and associated risk
factors in Chennai, South India. J Postgrad Med. 2014;60(1):3.
36. Sissoko D, Malvy D, Ezzedine K, Renault P, Moscetti F, Ledrans M, et
al. Post-epidemic Chikungunya disease on Reunion Island: Course of
rheumatic manifestations and associated factors over a 15-month period.
PLOS Negl Trop Dis. 2009 Mar 10;3(3):e389.
37. Essackjee K, Goorah S, Ramchurn SK, Cheeneebash J, Walker-Bone
K. Prevalence of and risk factors for chronic arthralgia and rheumatoid-like
polyarthritis more than 2 years after infection with chikungunya virus.
Postgrad Med J. 2013 Aug;89(1054):440-7.
38. Win MK, Chow A, Dimatatac F, Go CJ, Leo YS. Chikungunya fever in
Singapore: Acute clinical and laboratory features, and factors associated
with persistent arthralgia. J Clin Virol. 2010 Oct 1;49(2):111-4.
39. Chopra A, Anuradha V, Ghorpade R, Saluja M. Acute Chikungunya and
persistent musculoskeletal pain following the 2006 Indian epidemic: a 2-
year prospective rural community study. Epidemiol Amp Infect. 2012
May;140(5):842-50.
2. Powers AM, Brault AC, Shirako Y, Strauss EG, Kang W, Strauss JH, et al. Evolutionary relationships and systematics of the alphaviruses. J Virol. 2001 Nov;75(21):10118-31.
3. Robinson MC. An epidemic of virus disease in Southern Province, Tanganyika territory, in 1952-1953. Trans R Soc Trop Med Hyg. 1955 Jan 1;49(1):28-32.
4. Strauss JH, Strauss EG. The alphaviruses: gene expression, replication, and evolution. Microbiol Rev. 1994 Sep;58(3):491-562.
5. Jose J, Snyder JE, Kuhn RJ. A structural and functional perspective of alphavirus replication and assembly. Future Microbiol. 2009 Sep;4:837-56.
6. Thiberville S-D, Moyen N, Dupuis-Maguiraga L, Nougairede A, Gould
EA, Roques P, et al. Chikungunya fever: Epidemiology, clinical syndrome,
pathogenesis and therapy. Antiviral Res. 2013 Sep;99(3):345-70.
7. Suhrbier A, Jaffar-Bandjee M-C, Gasque P. Arthritogenic alphaviruses
—an overview. Nat Rev Rheumatol. 2012 Jul;8(7):420-9.
8. Halstead SB. Reappearance of Chikungunya, Formerly Called Dengue,
in the Americas. Emerg Infect Dis [Internet]. 2015 Apr [citado 2016 oct
25];21(4). Disponible en: http://wwwnc.cdc.gov/eid/article/21/4/14-
1723_article.htm.
9. Gérardin P, Guernier V, Perrau J, Fianu A, Le Roux K, Grivard P, et al.
Estimating Chikungunya prevalence in La Réunion Island outbreak by
serosurveys: Two methods for two critical times of the epidemic. BMC
Infect Dis. 2008 Jul 28;8:99.
10. Weaver SC, Lecuit M. Chikungunya virus and the global spread of a
mosquito-borne disease. N Engl J Med. 2015 Mar 26;372(13):1231-9.
11. Pialoux G, Gaüzère B-A, Jauréguiberry S, Strobel M. Chikungunya, an
epidemic arbovirosis. Lancet Infect Dis. 2007 May;7(5):319-27.
12. Mohan A, Kiran DHN, Manohar IC, Kumar DP. Epidemiology, clinical
manifestations, and diagnosis of Chikungunya fever: lessons learned from
the re-emerging epidemic. Indian J Dermatol. 2010 Jan;55(1):54-63.
13. Mavalankar D, Shastri P, Raman P. Chikungunya epidemic in India: A
major public-health disaster. Lancet Infect Dis. 2007 May;7(5):306-7.
14. Bhatia R, Narain JP. Re-emerging chikungunya fever: some lessons
from Asia. Trop Med Int Health. 2009 Aug 1;14(8):940-6.
15. Team EC for DP and C(ECDC)-HCU-E editorial. An outbreak of
chikungunya fever in the province of Ravenna, Italy. European Centre for
Disease Prevention and Control(ECDC) - Health Comunication Unit; 2007.
16. Van Bortel W, Dorleans F, Rosine J, Blateau A, Rousset D, Matheus S,
et al. Chikungunya outbreak in the Caribbean region, December 2013 to
March 2014, and the significance for Europe. Euro Surveill [Internet].
2014;19(13). Disponible en:
http://www.eurosurveillance.org/content/10.2807/1560-
7917.ES2014.19.13.20759#html_fulltext
17. Organización Panamericana de la Salud, Organización Mundial de la
Salud. Chikunguña: datos, mapas y estadísticas. Semana
epidemiológica/SE 42. 21 de octubre de 2016. 2016 [citado 2016 oct 25].
Disponible en: http://www.paho.org/hq/index.php?
option=com_topics&view=readall&cid=5932&Itemid=40931&lang=es.
18. Durán M, Gómez S. Chikunguña en Colombia, el inicio de la
transmisión autóctona, 2014. Inf Quinc Epidemiológico Nac [Internet].
2014;19(18). Disponible en: http://www.ins.gov.co/iqen/IQUEN/IQEN
%20vol %2019 %202014 %20num %2018.pdf.
19. Instituto Nacional de Salud. Boletín Epidemiológico Semanal
[Internet]. 2016 [citado 2016 oct 25];(41). Disponible en:
http://www.ins.gov.co/boletin-epidemiologico/Boletn
%20Epidemiolgico/2015 %20Boletin %20epidemiologico %20semana %2041.pdf.
20. Burt FJ, Rolph MS, Rulli NE, Mahalingam S, Heise MT. Chikungunya: a
re-emerging virus. The Lancet. 2012 Feb;379(9816):662-71.
21. Borgherini G, Poubeau P, Staikowsky F, Lory M, Moullec NL, Becquart
JP, et al. Outbreak of Chikungunya on Reunion Island: Early clinical and
laboratory features in 157 adult patients. Clin Infect Dis. 2007 Jun
1;44(11):1401-7.
22. Lo Presti A, Lai A, Cella E, Zehender G, Ciccozzi M. Chikungunya
virus, epidemiology, clinics and phylogenesis: A review. Asian Pac J Trop
Med. 2014 Dec 1;7(12):925-32.
23. Rezza G, Nicoletti L, Angelini R, Romi R, Finarelli A, Panning M, et al.
Infection with chikungunya virus in Italy: an outbreak in a temperate
region. The Lancet. 2007 Dec 7;370(9602):1840-6.
24. Paul BJ, Pannarkady G, Moni SP, Thachil EJ. Clinical profile and long-
term sequelae of Chikungunya fever. Indian J Rheumatol. 2011 Mar
1;6(1):12-9.
25. Daginawala H, Chandak N, Kashyap R, Kabra D, Karandikar P, Saha S,
et al. Neurological complications of Chikungunya virus infection. Neurol
India. 2009;57(2):177.
26. Moro ML, Grilli E, Corvetta A, Silvi G, Angelini R, Mascella F, et al.
Long-term chikungunya infection clinical manifestations after an outbreak
in Italy: A prognostic cohort study. J Infect. 2012 Aug 1;65(2):165-72.
27. World Health Organisation. Guidelines on clinical management of
chikunguña fever [Internet]. 2008 [citado 2016 oct 25]. Disponible en: http://www.wpro.who.int/mvp/topics/ntd/Clinical_Mgnt_Chikungunya_WH
O_SEARO.pdf.
28. de Andrade DC, Jean S, Clavelou P, Dallel R, Bouhassira D. Chronic
pain associated with the Chikungunya Fever: long lasting burden of an
acute illness. BMC Infect Dis. 2010;10:31.
29. Manimunda SP, Vijayachari P, Uppoor R, Sugunan AP, Singh SS, Rai
SK, et al. Clinical progression of chikungunya fever during acute and
chronic arthritic stages and the changes in joint morphology as revealed by
imaging. Trans R Soc Trop Med Hyg. 2010 Jun;104(6):392-9.
30. Larrieu S, Pouderoux N, Pistone T, Filleul L, Receveur M-C, Sissoko D,
et al. Factors associated with persistence of arthralgia among chikungunya
virus-infected travellers: Report of 42 French cases. J Clin Virol. 2010 Jan
1;47(1):85-8.
31. Borgherini G, Poubeau P, Jossaume A, Gouix A, Cotte L, Michault A, et
al. Persistent arthralgia associated with chikungunya virus: a study of 88
adult patients on reunion island. Clin Infect Dis Off Publ Infect Dis Soc Am.
2008;47(4):469-75.
32. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis
JPA, et al. The PRISMA statement for reporting systematic reviews and
meta-analyses of studies that evaluate healthcare interventions:
explanation and elaboration. BMJ. 2009 Dec 4;339(jul21 1):b2700-b2700.
33. Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The
Newcastle-Ottawa Scale(NOS) for assessing the quality of nonrandomised
studies in meta-analyses [Internet]. [Citado 2016 oct 25]. Disponible en:
http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
34. Schilte C, Staikovsky F, Couderc T, Madec Y, Carpentier F, Kassab S,
et al. Chikungunya virus-associated long-term arthralgia: a 36-month
prospective longitudinal study. PLOS Negl Trop Dis. 2013 Mar
21;7(3):e2137.
35. Ramachandran V, Kaur P, Kanagasabai K, Vadivoo S, Murhekar M.
Persistent arthralgia among Chikungunya patients and associated risk
factors in Chennai, South India. J Postgrad Med. 2014;60(1):3.
36. Sissoko D, Malvy D, Ezzedine K, Renault P, Moscetti F, Ledrans M, et
al. Post-epidemic Chikungunya disease on Reunion Island: Course of
rheumatic manifestations and associated factors over a 15-month period.
PLOS Negl Trop Dis. 2009 Mar 10;3(3):e389.
37. Essackjee K, Goorah S, Ramchurn SK, Cheeneebash J, Walker-Bone
K. Prevalence of and risk factors for chronic arthralgia and rheumatoid-like
polyarthritis more than 2 years after infection with chikungunya virus.
Postgrad Med J. 2013 Aug;89(1054):440-7.
38. Win MK, Chow A, Dimatatac F, Go CJ, Leo YS. Chikungunya fever in
Singapore: Acute clinical and laboratory features, and factors associated
with persistent arthralgia. J Clin Virol. 2010 Oct 1;49(2):111-4.
39. Chopra A, Anuradha V, Ghorpade R, Saluja M. Acute Chikungunya and
persistent musculoskeletal pain following the 2006 Indian epidemic: a 2-
year prospective rural community study. Epidemiol Amp Infect. 2012
May;140(5):842-50.
Cómo citar
Caicedo Ochoa, E. Y., Urrutia Gómez, J. A., Niño Fernández, D. S., & Mendez Fandiño, Y. R. (2018). Revisión sistemática sobre factores de riesgo asociados a artralgia persistente en el paciente con fiebre del chikunguña. Universitas Medica, 59(2). https://doi.org/10.11144/Javeriana.umed59-2.chik
Número
Sección
Artículos de revisión